Original Research Online Publishing Date: | ||||||||||||||||||||||||||||||
Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study Prathibha V K, Mukundan C, Bhagyalekshmi N.
|
How to Cite this Article |
Pubmed Style K PV, C M, N B. Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. Natl J Physiol Pharm Pharmacol. 2020; 10(5): 423-430. doi:10.5455/njppp.2020.10.04081202004042020 Web Style K PV, C M, N B. Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. https://www.njppp.com/?mno=96255 [Access: March 14, 2024]. doi:10.5455/njppp.2020.10.04081202004042020 AMA (American Medical Association) Style K PV, C M, N B. Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. Natl J Physiol Pharm Pharmacol. 2020; 10(5): 423-430. doi:10.5455/njppp.2020.10.04081202004042020 Vancouver/ICMJE Style K PV, C M, N B. Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. Natl J Physiol Pharm Pharmacol. (2020), [cited March 14, 2024]; 10(5): 423-430. doi:10.5455/njppp.2020.10.04081202004042020 Harvard Style K, P. V., C, . M. & N, . B. (2020) Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. Natl J Physiol Pharm Pharmacol, 10 (5), 423-430. doi:10.5455/njppp.2020.10.04081202004042020 Turabian Style K, Prathibha V, Mukundan C, and Bhagyalekshmi N. 2020. Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (5), 423-430. doi:10.5455/njppp.2020.10.04081202004042020 Chicago Style K, Prathibha V, Mukundan C, and Bhagyalekshmi N. "Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 423-430. doi:10.5455/njppp.2020.10.04081202004042020 MLA (The Modern Language Association) Style K, Prathibha V, Mukundan C, and Bhagyalekshmi N. "Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study." National Journal of Physiology, Pharmacy and Pharmacology 10.5 (2020), 423-430. Print. doi:10.5455/njppp.2020.10.04081202004042020 APA (American Psychological Association) Style K, P. V., C, . M. & N, . B. (2020) Ivabradine alone and in combination with metoprolol reduces the incidence of major adverse cardiac events in patients with heart failure: A prospective study. National Journal of Physiology, Pharmacy and Pharmacology, 10 (5), 423-430. doi:10.5455/njppp.2020.10.04081202004042020 |